First inflation-rebate drug prices hit April 1 in rollout of CMS drug policy
CMS has rolled out its first wave of Part B and Part D drug policy innovations, and medical groups and some patients and providers will feel some effects — specifically lower co-insurance for Medicare beneficiaries on 27 drugs, effective April 1 — pretty quickly. Others will take time to kick in.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.